French Glendon E. III (CIK 1805624) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell LUNG (13,511 shares), Sell LUNG (4,171 shares), Sell LUNG (38,467 shares), Sell LUNG (2,708 shares), Sell LUNG (6,737 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Pulmonx Corp (LUNG) | President and CEO | Sell | 13,511 | $21,212 |
| 2026-06-03 | Pulmonx Corp (LUNG) | President and CEO | Sell | 4,171 | $6,423 |
| 2026-06-03 | Pulmonx Corp (LUNG) | President and CEO | Sell | 38,467 | $59,239 |
| 2026-03-04 | Pulmonx Corp (LUNG) | President and CEO | Sell | 2,708 | $3,872 |
| 2026-03-04 | Pulmonx Corp (LUNG) | President and CEO | Sell | 6,737 | $9,634 |
| 2026-03-04 | Pulmonx Corp (LUNG) | President and CEO | Sell | 58,368 | $83,466 |
| 2025-12-03 | Pulmonx Corp (LUNG) | President and CEO | Sell | 6,281 | $9,861 |
| 2025-12-03 | Pulmonx Corp (LUNG) | President and CEO | Sell | 2,524 | $3,963 |
| 2025-12-03 | Pulmonx Corp (LUNG) | President and CEO | Buy | 1.2M | $0 |
| 2025-06-04 | Pulmonx Corp (LUNG) | Director | Buy | 37,153 | $0 |
| 2025-03-21 | Pulmonx Corp (LUNG) | Director | Sell | 20,000 | $157,000 |
| 2025-02-24 | Pulmonx Corp (LUNG) | Director | Sell | 43,036 | $350,313 |
| 2025-02-24 | Pulmonx Corp (LUNG) | Director | Sell | 12,417 | $108,773 |
| 2025-01-21 | Pulmonx Corp (LUNG) | Director | Sell | 2,221 | $14,436 |
| 2025-01-21 | Pulmonx Corp (LUNG) | Director | Sell | 2,326 | $15,189 |
Source: SEC Form 4 filings · as of 2026-06-03